Rafferty Asset Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-137,472
| Closed | -$1.72M | – | 1163 |
|
|
2022
Q3 | $1.72M | Buy |
+137,472
| New | +$1.72M | 0.02% | 543 |
|
|
2022
Q2 | – | Sell |
-256,500
| Closed | -$1.95M | – | 1248 |
|
|
2022
Q1 | $1.95M | Sell |
256,500
-89,624
| -26% | -$681K | 0.01% | 604 |
|
|
2021
Q4 | $3.53M | Buy |
346,124
+136,288
| +65% | +$1.39M | 0.02% | 501 |
|
|
2021
Q3 | $2.82M | Buy |
209,836
+89,181
| +74% | +$1.2M | 0.02% | 518 |
|
|
2021
Q2 | $2.65M | Sell |
120,655
-22,042
| -15% | -$484K | 0.02% | 557 |
|
|
2021
Q1 | $3.43M | Buy |
142,697
+113,946
| +396% | +$2.74M | 0.02% | 401 |
|
|
2020
Q4 | $517K | Sell |
28,751
-39,830
| -58% | -$716K | 0.01% | 679 |
|
|
2020
Q3 | $792K | Buy |
68,581
+56,675
| +476% | +$655K | 0.01% | 611 |
|
|
2020
Q2 | $289K | Buy |
+11,906
| New | +$289K | ﹤0.01% | 838 |
|
|
2020
Q1 | – | Sell |
-37,648
| Closed | -$995K | – | 834 |
|
|
2019
Q4 | $995K | Sell |
37,648
-11,557
| -23% | -$305K | 0.02% | 553 |
|
|
2019
Q3 | $1.12M | Sell |
49,205
-8,296
| -14% | -$189K | 0.02% | 512 |
|
|
2019
Q2 | $1.76M | Buy |
57,501
+1,782
| +3% | +$54.6K | 0.03% | 451 |
|
|
2019
Q1 | $925K | Buy |
+55,719
| New | +$925K | 0.01% | 564 |
|